Health
Gene Found that Causes EGFR-Driven Lung Cancer to Return After Treatment – Clinical OMICs News
The authors noted that “augmented levels of AXL and GAS6 have been found to drive resistance to EGFR tyrosine kinase inhibitors…
Approximately 15% of non-small cell lung cancers have a mutation in a growth receptor called EGFR, causing tumor cells to grow uncontrollably. Researchers developed an effective drug that inhibits EGFR and kills cancer cells. However, the tumors can grow…
Continue Reading
-
General9 hours agoAlleged Croydon Park gunman Artemios Mintzas charged with 25 offences
-
Noosa News23 hours agoProtest calls for shark net removal
-
General22 hours agoThree youths in police custody after fire at Ashley Youth Detention Centre in northern Tasmania
-
General15 hours agoTeam Australia wins back-to-back Motocross of Nations titles